Press Coverage

You are here

04/17/2017

A new piece by Brian Zikmund-Fisher and former CBSSM post-doc, Laura Scherer is out in the Conversation, "Maximizers vs. minimizers: The personality trait that may guide your medical decisions – and costs."

Research Topics: 
03/20/2017

A 2014 Reshma Jagsi study of the Long-Term Impact of Chemotherapy on Breast Cancer Survivors was cited by NPR piece, "As Drug Costs Soar, People Delay Or Skip Cancer Treatments."

03/01/2017

Interim co-director, Brian Zikmund-Fisher, as well as former co-director, Angela Fagerlin, were recently featured in a Wall Street Journal article, "How to Get Patients to Take More Control of Their Medical Decisions."

02/15/2017

According to a study by Reshma Jagsi and colleagues, doctors often fail to recommend genetic testing for breast-cancer patients, even those who are at high risk for mutations linked to ovarian and other cancers. They surveyed 2,529 breast-cancer patients and found that although two-thirds of the women reported wanting genetic testing, less than a third actually got it. About 8 in 10 women at highest risk for BRCA mutations — because of family history or ancestry — said they had wanted testing, but only a little more than half received it.

02/01/2017
Sarah Hawley and Reshma Jagsi are co-authors on two studies of the impact of doctor-patient communication on patients' perceptions of their breast cancer recurrence risk. They found that breast cancer patients commonly overestimate their risk of recurrence, which was a negative impact on their quality of life. The two studies were highlighted in a MHealth Lab Report. Brian Zikmund-Fisher was also co-author on one of these studies.

Pages